You just read:

New INGREZZA® (valbenazine) Analysis Published in the Journal of Affective Disorders Demonstrates Sustained Improvement in Tardive Dyskinesia Symptoms in Patients with Primary Mood Disorders

News provided by

Neurocrine Biosciences, Inc.

Jan 16, 2019, 16:01 ET